Article Text

Download PDFPDF
CASE REPORT
Bleomycin-induced flagellate dermatitis
  1. Rachel Grynszpan,
  2. João Paulo Niemeyer-Corbellini,
  3. Marien Siqueira Soto Lopes,
  4. Marcia Ramos-e-Silvahttp://orcid.org/0000-0003-1625-0760
  1. Sector of Dermatology, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
  1. Correspondence to Professor Marcia Ramos-e-Silva, ramos.e.silva{at}dermato.med.br

Summary

Flagellate dermatitis shows very characteristic lesions: linear erythema or hyperpigmentation in various areas of the skin. It is a side effect of bleomycin, an immunosupressive drug used for several types of cancers. All physicians must be aware of this disease so they can make a rapid diagnosis and interrupt the causative agent. Our patient presented during chemotherapy for a Hodgkin's lymphoma pruritic, erythematous lesions on the lower limbs and the back diagnosed as flagellate dermatitis due to bleomycin.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.